Douglas Pharmaceuticals - Latest News [Page 1]
Douglas Pharmaceuticals Secures US Licensing Deal To Treat High Grade Cervical Dysplasia
Tuesday, 12 September 2023, 3:53 pm | Douglas Pharmaceuticals
Auckland based Douglas Pharmaceuticals has signed a license agreement with U.S based Daré Bioscience, Inc to develop and commercialise R-131-2, a novel topical medicinal candidate for the treatment for cervical intraepithelial neoplasia. Managing Director ... More >>
